Considering Addition of Acetazolamide to Loop Diuretics as Treatment for Acute Heart Failure: ADVOR Reappraisal

JACC Heart Fail. 2023 Mar;11(3):365-367. doi: 10.1016/j.jchf.2023.01.011.

Authors

Stephen J Greene¹, G Michael Felker²

Affiliations

¹ Duke Clinical Research Institute, Durham, North Carolina, USA; Division of Cardiology, Duke University School of Medicine, Durham, North Carolina, USA.
² Duke Clinical Research Institute, Durham, North Carolina, USA; Division of Cardiology, Duke University School of Medicine, Durham, North Carolina, USA. Electronic address: https://twitter.com/DukeHFDoc.

PMID: 36889884
DOI: 10.1016/j.jchf.2023.01.011

No abstract available

Keywords: acetazolamide; congestion; diuretic; heart failure; hospital.

Publication types

Editorial

MeSH terms

Acetazolamide* / therapeutic use
Diuretics / therapeutic use
Heart Failure* / drug therapy
Humans
Sodium Potassium Chloride Symporter Inhibitors / therapeutic use
Treatment Outcome

Substances

Acetazolamide
Sodium Potassium Chloride Symporter Inhibitors
Diuretics